SCHEMBL17609152

SCHEMBL17609152

O=CCc1ccc(Nc2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.58
AR P10275 5/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HPGD P15428 1/20 0.54
SIRT2 Q8IXJ6 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
BLM P54132 1/20 0.52
ATM Q13315 1/20 0.52
LTA4H P09960 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42303 0.90 BCHE (0.65) BCHERAB9ASMN1; SMN2GAAMAPT
SCHEMBL22265220 0.85 APP (0.60) BCHENPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11714868 0.85 MEN1 (0.67) BCHEARNPC1RAB9ASMN1; SMN2
SCHEMBL6608023 0.81 ALDH1A1 (0.56) ARRAB9AHPGDMEN1KMT2A
SCHEMBL19382100 0.81 AR (0.59) BCHEARNPC1RAB9ASMN1; SMN2
SCHEMBL2113895 0.80 CYP1A2 (0.57) BCHEARNPC1RAB9ASMN1; SMN2
Sulfurous Acid SCHEMBL28555351 0.79 LMNA (0.51) BCHELTA4HCYP1A2CYP2C19
SCHEMBL17609128 0.79 ALOX5 (0.54) BCHEAR
SCHEMBL1465278 0.79 KMT2A (0.70) BCHEARNPC1RAB9ASMN1; SMN2
SCHEMBL866939 0.79 NPC1 (0.60) BCHEARNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3193601-A1 HISTONE DEMETHYLASE INHIBITORS Celgene Quanticel Research, Inc. (US) 2017-07-26 EP disclosed
WO-2016044429-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2016-03-24 WO disclosed